Literature DB >> 12573189

Cardiovascular risk in diabetic women.

Chara Bolego1, Andrea Poli, Rodolfo Paoletti.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12573189     DOI: 10.1007/s11883-003-0074-2

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  14 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 3.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Diabetes abolishes the vascular protective effects of estrogen in female rats.

Authors:  C Bolego; A Cignarella; V Zancan; C Pinna; R Zanardo; L Puglisi
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 5.  Diabetes mellitus and cardiovascular disease in women.

Authors:  J R Sowers
Journal:  Arch Intern Med       Date:  1998-03-23

6.  Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study.

Authors:  B V Howard; L D Cowan; O Go; T K Welty; D C Robbins; E T Lee
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

7.  Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study.

Authors:  E Barrett-Connor; D L Wingard
Journal:  Am J Epidemiol       Date:  1983-10       Impact factor: 4.897

8.  Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

Authors:  E L Barrett-Connor; B A Cohn; D L Wingard; S L Edelstein
Journal:  JAMA       Date:  1991-02-06       Impact factor: 56.272

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.